Bioray Biotech Co., Ltd (TPEX:7561)

Market Cap	705.61M +21.0%
Revenue (ttm)	230.06M +25.3%
Net Income	30.50M
EPS	1.03
Shares Out	29.59M
PE Ratio	23.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,000
Average Volume	14,248
Open	24.10
Previous Close	23.90
Day's Range	23.85 - 24.20
52-Week Range	18.25 - 32.10
Beta	0.34
RSI	54.06
Earnings Date	Apr 20, 2026

About Bioray Biotech

Bioray Biotech Co., Ltd engages in the production, research, and sells health foods, immune cell products, and precision testing services in Taiwan. It offers health care products, including various functional foods and supplements; medicinal fungi; immune cell products; and precision medicine services, such as immunology, cell division, and specialized laboratory testing. The company is also involved in the cell testing and storage business. Bioray Biotech Co., Ltd was founded in 2005 and is based in Tainan City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7561